As Vice Chair, Dr. Susan E Cohn will work closely with Dr. Rosie Mngqbisa, A5338 Chair, and Dr. Jennifer Robinson, co-Vice Chair, to oversee the overall conduct of this clinical trial, and with the entire study team to respond to the sites questions about the study, procedures and/or patient eligibility concerns, review safety reports with the A5338 Core team and ensure the Team responds via email promptly, participate on regular and ad hoc A5338 Team calls, and help to ensure that the protocol is enrolled and conducted in a timely fashion. After study completion, Dr. Cohn will work with the A5338 Team to review the final data report and work with the A5316 Writing team to write and finalize manuscripts describing study outcomes and safety.
|Effective start/end date||12/1/15 → 11/30/17|
- Brigham and Womens Hospital (110229//5UM1AI068636-10)
- National Institute of Allergy and Infectious Diseases (110229//5UM1AI068636-10)